Literature DB >> 12355253

Influence of the bovine seminal plasma protein PDC-109 on cholesterol in the presence of phospholipids.

Peter Müller1, Alexa Greube, Edda Töpfer-Petersen, Andreas Herrmann.   

Abstract

The interaction of the major bovine seminal plasma protein PDC-109 with cholesterol was studied by employing spin-labelled analogues. It could be shown that PDC-109 does not interact directly with cholesterol molecules. However, in the presence of phospholipids we found a strong reduction of cholesterol motion by PDC-109. The fraction of immobilized cholesterol was largest for phosphorylcholine-containing lipids. This is consistent with the preferential interaction between PDC-109 and phosphatidylcholine. It is concluded that a stronger association and interaction of PDC-109 with phosphatidylcholine leads to an enhanced fraction of immobilized cholesterol analogues, but not to a phospholipid-dependent specific interaction between the protein and cholesterol. Moreover, the interaction of PDC-109 with various spin-labelled analogues of phosphatidylcholine (lysoPC, diacylPC) was investigated. In membranes of lipid vesicles the protein caused an immobilization of the phosphatidylcholine analogues mainly in the outer membrane leaflet, with no differences between diacylPC and lysoPC. The results are of relevance for understanding the physiological role of PDC-109 in the genesis of sperm cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12355253     DOI: 10.1007/s00249-002-0234-2

Source DB:  PubMed          Journal:  Eur Biophys J        ISSN: 0175-7571            Impact factor:   1.733


  2 in total

Review 1.  Mammalian sperm interactions with the female reproductive tract.

Authors:  Susan S Suarez
Journal:  Cell Tissue Res       Date:  2015-07-17       Impact factor: 5.249

2.  The Bovine Seminal Plasma Protein PDC-109 Possesses Pan-Antiviral Activity.

Authors:  Hannah Sabeth Sperber; Kathrin Sutter; Karin Müller; Peter Müller; Roland Schwarzer
Journal:  Viruses       Date:  2022-09-13       Impact factor: 5.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.